Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
HeartCore Enterprises
HTCR
$23M
| $182K | ﹤0.01% |
127,560
+102,057
| +400% | +$146K |
|
3327
USCB Financial Holdings
USCB
$350M
| $180K | ﹤0.01% |
17,600
+1,600
| +10% | +$16.4K |
|
3328
First Savings Financial Group
FSFG
$193M
| $178K | ﹤0.01% |
13,400
+400
| +3% | +$5.31K |
|
|
CTO
3329
CTO Realty Growth
CTO
$546M
| $177K | ﹤0.01% |
+10,301
| New | +$177K |
|
3330
Spyre Therapeutics
SYRE
$978M
| $177K | ﹤0.01% |
15,720
+8,476
| +117% | +$95.4K |
|
3331
Janux Therapeutics
JANX
$1.51B
| $176K | ﹤0.01% |
+14,800
| New | +$176K |
|
3332
Aegon
AEG
$12.1B
| $168K | ﹤0.01% |
33,167
-266,429
| -89% | -$1.35M |
|
3333
XBiotech
XBIT
$86M
| $168K | ﹤0.01% |
28,335
-24,160
| -46% | -$143K |
|
3334
AEye
LIDR
$106M
| $167K | ﹤0.01% |
30,803
+17,336
| +129% | +$94K |
|
3335
TeraWulf
WULF
$4.34B
| $167K | ﹤0.01% |
+95,200
| New | +$167K |
|
3336
Scienjoy Holding
SJ
$31.8M
| $164K | ﹤0.01% |
59,700
+5,400
| +10% | +$14.8K |
|
|
OPTN
3337
DELISTED
OptiNose
OPTN
| $163K | ﹤0.01% |
8,820
-4,107
| -32% | -$75.9K |
|
3338
Inspirato
ISPO
$37.2M
| $162K | ﹤0.01% |
8,275
+6,065
| +274% | +$119K |
|
3339
Soho House & Co
SHCO
$1.73B
| $162K | ﹤0.01% |
29,800
-26,500
| -47% | -$144K |
|
|
TRVN
3340
DELISTED
Trevena, Inc.
TRVN
| $160K | ﹤0.01% |
7,286
+4,465
| +158% | +$98.1K |
|
3341
Esperion Therapeutics
ESPR
$563M
| $159K | ﹤0.01% |
+114,300
| New | +$159K |
|
3342
NexGen Energy
NXE
$4.5B
| $159K | ﹤0.01% |
33,800
-183,600
| -84% | -$864K |
|
3343
SIFCO Industries
SIF
$44.8M
| $159K | ﹤0.01% |
64,434
+3,700
| +6% | +$9.13K |
|
3344
Alpha Teknova
TKNO
$239M
| $159K | ﹤0.01% |
59,700
-22,000
| -27% | -$58.6K |
|
|
FNCB
3345
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $159K | ﹤0.01% |
26,598
+5,898
| +28% | +$35.3K |
|
|
RBT
3346
DELISTED
Rubicon Technologies, Inc.
RBT
| $159K | ﹤0.01% |
53,600
+46,387
| +643% | +$138K |
|
3347
ESS Tech
GWH
$20.5M
| $158K | ﹤0.01% |
7,160
-2,920
| -29% | -$64.4K |
|
|
SOGP
3348
Sound Group
SOGP
$100M
| $158K | ﹤0.01% |
17,360
+200
| +1% | +$1.82K |
|
3349
Beasley Broadcasting Group
BBGI
$9.24M
| $157K | ﹤0.01% |
7,716
+500
| +7% | +$10.2K |
|
|
BLRX
3350
BioLineRX
BLRX
$17.1M
| $157K | ﹤0.01% |
2,468
-184
| -7% | -$11.7K |
|